Skip to main content
Earnings Labs
NewAmsterdam Pharma Company N.V. logo

NewAmsterdam Pharma Company N.V. (NAMS) Earnings

NASDAQ·Healthcare·Biotechnology

$22.65

-2.87%

Mkt Cap $2.47B

EPS — Estimate vs Actual

Mkt Cap

$2.47B

P/E

Fwd P/E

P/S

109.63

Rev TTM

EPS TTM

-$1.81